NuVasive, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NUVA research report →
Companywww.nuvasive.com
NuVasive, Inc. , a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal implants to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone; and fixation system that facilitates the preservation and restoration of patient alignment.
- CEO
- J. Christopher Barry
- IPO
- 2004
- Employees
- 3,000
- HQ
- San Diego, CA, US
Price Chart
Valuation
- Market Cap
- $2.08B
- P/E
- 56.43
- P/S
- 1.73
- P/B
- 2.62
- EV/EBITDA
- 19.11
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 72.00%
- Op Margin
- 5.39%
- Net Margin
- 3.36%
- ROE
- 4.86%
- ROIC
- 2.54%
Growth & Income
- Revenue
- $1.20B · 5.53%
- Net Income
- $40.41M · 163.05%
- EPS
- $0.78 · 162.90%
- Op Income
- $64.77M
- FCF YoY
- -57.41%
Performance & Tape
- 52W High
- $49.53
- 52W Low
- $35.17
- 50D MA
- $40.83
- 200D MA
- $41.23
- Beta
- 1.07
- Avg Volume
- 1.41M
Get TickerSpark's AI analysis on NUVA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 1, 23 | Wolterman Dan | sell | 4,816 |
| Sep 1, 23 | Raimundo Amy Belt | sell | 4,816 |
| Sep 1, 23 | Norwalk Leslie V | sell | 3,095 |
| Sep 1, 23 | Norwalk Leslie V | sell | 4,816 |
| Sep 1, 23 | Kadia Siddhartha | sell | 4,816 |
| Sep 1, 23 | Kadia Siddhartha | sell | 3,739 |
| Sep 1, 23 | Huennekens R Scott | sell | 4,816 |
| Sep 1, 23 | Huennekens R Scott | sell | 1,360 |
| Sep 1, 23 | FRIEL ROBERT F | sell | 4,816 |
| Sep 1, 23 | DeFord John A | sell | 3,788 |
Our NUVA Coverage
We haven't published any research on NUVA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate NUVA Report →